How do autogenous vaccines fit into the Poultry Vaccines Market value chain?

Autogenous (custom) vaccines are farm-specific biologics manufactured from pathogens isolated on a particular premises. They fill gaps where licensed commercial products lack strain-matched coverage, typically representing 3–5% of total vaccine expenditure in mature markets [17]. Read More

What shelf-life challenges do liquid poultry vaccines face during last-mile delivery?

Most liquid formulations require 2–8°C storage and lose potency within 2 hours of reconstitution. This limits usability in tropical off-grid regions and drives demand for lyophilized alternatives with 30+ day ambient stability [8]. Read More

How does in-ovo injection timing affect vaccine efficacy in broiler hatcheries?

Embryonated eggs vaccinated at 18 days of incubation achieve 92–96% seroconversion rates. Timing precision is critical — injection outside the 17.5–18.5 day window reduces immune response uniformity by up to 20% [7]. Read More

What role do adjuvants play in inactivated poultry vaccine formulations?

Oil-in-water and aluminium-based adjuvants boost immune response duration from 4–6 weeks to 20+ weeks, essential for breeder and layer birds requiring long-lived immunity across extended production cycles [17]. Read More

How are biosecurity audits linked to vaccination compliance in export markets?

Major importers — including the EU, Japan, and Saudi Arabia — require OIE-compliant vaccination records as part of export health certification. Non-compliant flocks face trade exclusion regardless of disease-free status [9]. Read More

What intellectual property barriers exist for new entrants in the Poultry Vaccines Market?

Recombinant HVT-vector technology is protected by 60+ active patent families held primarily by Boehringer Ingelheim, Ceva, and Merck. New entrants typically require licensing agreements or must pursue alternative vector backbones [4]. Read More

How do combination vaccines reduce total cost of ownership for integrated producers?

Multivalent in-ovo constructs cut total vaccination events from 6–8 to 2–3 per flock cycle. Integrated producers report 18–25% reductions in per-bird immunization costs through fewer handling rounds and lower labour inputs [7]. Read More

Poultry Vaccines Market (2026 - 2035)

Poultry Vaccines Market Research Report By Type (Live Attentuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation), By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2026-2035

CAGR

9.55%

2019 Market Size

2.45 USD Billion

2021 Market Size

2.66 USD Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/6046-HCR | Pages: 200 | Author: Vikita Thakur, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Antibiotic-Reduction Regulations | |
  2. 3.1.2 H5N1 Clade
  3. 3.1.3 Recombinant HVT Vector Platform Adoption | |
  4. 3.1.4 Vertical Integration in Asia-Pacific Poultry | |
  5. 3.1.5 Thermostable Formulation Expansion | |
  6. 3.1.6 Digitized Cold-Chain and E-Ordering Platforms | |
  7. 3.1.7 Government Stockpiling Programs |
2. 2.3.4.4b Outbreak Cycles | |
3. 3.2 Market Restraints Analysis | |
  1. 3.2.1 Cold-Chain Infrastructure Gaps | |
  2. 3.2.2 Counterfeit and Substandard Vaccines | |
  3. 3.2.3 Regulatory Fragmentation Across Markets | |
  4. 3.2.4 Price Sensitivity in Smallholder Flocks | |
  5. 3.2.5 Vaccine Interference and Field-Reversion Risks |
4. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Thermostable Formulations for Off-Grid Markets | |
  2. 3.3.2 In-Ovo Vaccination Automation | |
  3. 3.3.3 mRNA and Next-Generation Platform Vaccines | |
  4. 3.3.4 Data-Driven Vaccination-as-a-Service | |
  5. 3.3.5 Expansion into Aquaculture-Adjacent Biologics |
5. 3.4 Industry Value Chain Analysis |
6. 3.5 Porter's Five Forces Analysis
4 Global Poultry Vaccines Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Disease Type | |
  1. 5.1.1 Infectious Bronchitis | |
  2. 5.1.2 Avian Influenza | |
  3. 5.1.3 Newcastle Disease | |
  4. 5.1.4 Infectious Bursal Disease (Gumboro) | |
  5. 5.1.5 Marek's Disease | |
  6. 5.1.6 Others |
2. 5.2 By Technology | |
  1. 5.2.1 Live Attenuated Vaccines | |
  2. 5.2.2 Inactivated / Killed Vaccines | |
  3. 5.2.3 Recombinant / Vector Vaccines | |
  4. 5.2.4 Toxoid and Subunit Vaccines |
3. 5.3 By Application | |
  1. 5.3.1 Breeder Flocks | |
  2. 5.3.2 Layer Flocks | |
  3. 5.3.3 Broiler Flocks |
4. 5.4 By Dosage Form | |
  1. 5.4.1 Liquid Formulations | |
  2. 5.4.2 Powder / Lyophilized | |
  3. 5.4.3 Dust and Aerosol |
5. 5.5 By Route of Administration | |
  1. 5.5.1 Injectable | |
  2. 5.5.2 Drinking Water | |
  3. 5.5.3 Intranasal / Spray | |
  4. 5.5.4 In-Ovo |
6. 5.6 By End User | |
  1. 5.6.1 Poultry Farms | |
  2. 5.6.2 Veterinary Clinics & Hospitals | |
  3. 5.6.3 Government & Research Institutes |
7. 5.7 By Distribution Channel | |
  1. 5.7.1 Hospital / Veterinary Pharmacies | |
  2. 5.7.2 Direct Sales / Manufacturer Channels | |
  3. 5.7.3 Online Platforms
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Zoetis Inc. | |
  2. 7.3.2 Merck Animal Health (MSD) | |
  3. 7.3.3 Boehringer Ingelheim | |
  4. 7.3.4 Ceva Santé Animale | |
  5. 7.3.5 Elanco Animal Health | |
  6. 7.3.6 HIPRA | |
  7. 7.3.7 Phibro Animal Health | |
  8. 7.3.8 Hester Biosciences | |
  9. 7.3.9 Vaxxinova (EW Group) | |
  10. 7.3.10 Venky's (India) Ltd.
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 Precision Vaccinology and AI-Driven Flock Analytics |
2. 8.2 mRNA and Synthetic Biology Platforms |
3. 8.3 Sustainability and ESG-Aligned Poultry Production |
4. 8.4 Traceability, Serialization, and Digital Supply Chains
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Poultry Vaccines Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Poultry Vaccines Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Market Driver Impact Analysis — Poultry Vaccines Market |
TABLE 4 Market Restraint Impact Analysis — Poultry Vaccines Market |
TABLE 5 Global Poultry Vaccines Market Size, by Disease Type, 2021–2035 (USD Billion) |
TABLE 6 Global Poultry Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 7 Global Poultry Vaccines Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 8 Global Poultry Vaccines Market Size, by Dosage Form, 2021–2035 (USD Billion) |
TABLE 9 Global Poultry Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 10 Global Poultry Vaccines Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 11 Global Poultry Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 12 Global Poultry Vaccines Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 13 North America Poultry Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Europe Poultry Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 15 Asia-Pacific Poultry Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 16 South America Poultry Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 17 Middle East & Africa Poultry Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 18 Competitive Benchmarking Matrix — Global Poultry Vaccines Market, 2025 |
TABLE 19 Company Profiles — Key Players, Global Poultry Vaccines Market |
TABLE 20 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 21 Report Scope & Methodology Summary |
TABLE 22 Detailed Sources and Citations |
TABLE 23 North America Poultry Vaccines Market Size, by Disease Type, 2021–2035 (USD Billion) |
TABLE 24 North America Poultry Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 25 North America Poultry Vaccines Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 26 North America Poultry Vaccines Market Size, by Dosage Form, 2021–2035 (USD Billion) |
TABLE 27 North America Poultry Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 28 North America Poultry Vaccines Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 29 North America Poultry Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 30 Europe Poultry Vaccines Market Size, by Disease Type, 2021–2035 (USD Billion) |
TABLE 31 Europe Poultry Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 32 Europe Poultry Vaccines Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 33 Europe Poultry Vaccines Market Size, by Dosage Form, 2021–2035 (USD Billion) |
TABLE 34 Europe Poultry Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 35 Europe Poultry Vaccines Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 36 Europe Poultry Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 37 Asia-Pacific Poultry Vaccines Market Size, by Disease Type, 2021–2035 (USD Billion) |
TABLE 38 Asia-Pacific Poultry Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 39 Asia-Pacific Poultry Vaccines Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 40 Asia-Pacific Poultry Vaccines Market Size, by Dosage Form, 2021–2035 (USD Billion) |
TABLE 41 Asia-Pacific Poultry Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 42 Asia-Pacific Poultry Vaccines Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 43 Asia-Pacific Poultry Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 44 South America Poultry Vaccines Market Size, by Disease Type, 2021–2035 (USD Billion) |
TABLE 45 South America Poultry Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 46 South America Poultry Vaccines Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 47 South America Poultry Vaccines Market Size, by Dosage Form, 2021–2035 (USD Billion) |
TABLE 48 South America Poultry Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 49 South America Poultry Vaccines Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 50 South America Poultry Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 51 Middle East & Africa Poultry Vaccines Market Size, by Disease Type, 2021–2035 (USD Billion) |
TABLE 52 Middle East & Africa Poultry Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 53 Middle East & Africa Poultry Vaccines Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 54 Middle East & Africa Poultry Vaccines Market Size, by Dosage Form, 2021–2035 (USD Billion) |
TABLE 55 Middle East & Africa Poultry Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 56 Middle East & Africa Poultry Vaccines Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 57 Middle East & Africa Poultry Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion)
13 LIST OF FIGURES |
FIGURE 1 Poultry Vaccines Market Dynamics — Drivers, Restraints, and Opportunities |
FIGURE 2 Value Chain Analysis — Global Poultry Vaccines Market |
FIGURE 3 Porter's Five Forces Analysis — Poultry Vaccines Market |
FIGURE 4 Global Poultry Vaccines Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Poultry Vaccines Market Share, by Disease Type (%), 2025 |
FIGURE 6 Poultry Vaccines Market Share, by Technology (%), 2025 |
FIGURE 7 Poultry Vaccines Market Share, by Application (%), 2025 |
FIGURE 8 Poultry Vaccines Market Share, by Dosage Form (%), 2025 |
FIGURE 9 Poultry Vaccines Market Share, by Route of Administration (%), 2025 |
FIGURE 10 Poultry Vaccines Market Share, by End User (%), 2025 |
FIGURE 11 Poultry Vaccines Market Share, by Distribution Channel (%), 2025 |
FIGURE 12 Poultry Vaccines Market Share, by Region (%), 2025 |
FIGURE 13 North America Poultry Vaccines Market Share, by Country (%), 2025 |
FIGURE 14 Europe Poultry Vaccines Market Share, by Country (%), 2025 |
FIGURE 15 Asia-Pacific Poultry Vaccines Market Share, by Country (%), 2025 |
FIGURE 16 South America Poultry Vaccines Market Share, by Country (%), 2025 |
FIGURE 17 Middle East & Africa Poultry Vaccines Market Share, by Country (%), 2025 |
FIGURE 18 Competitive Landscape — Global Poultry Vaccines Market, 2025

Certified Researchers

Customize Report

SEGMENTATION QUICK REFERENCE

Dimension	Sub-Segments	Dominant Segment (2025)	Fastest Growing Segment (2026–2035)
Disease Type	Infectious Bronchitis, Avian Influenza, Newcastle Disease, Infectious Bursal Disease, Marek's Disease, Others	Infectious Bronchitis	Avian Influenza
Technology	Live Attenuated, Inactivated / Killed, Recombinant / Vector, Toxoid and Subunit	Live Attenuated Vaccines	Recombinant / Vector Vaccines
Application	Breeder Flocks, Layer Flocks, Broiler Flocks	Breeder Flocks	Layer Flocks
Dosage Form	Liquid, Powder / Lyophilized, Dust and Aerosol	Liquid Formulations	Powder / Lyophilized
Route of Administration	Injectable, Drinking Water, Intranasal / Spray, In-Ovo	Injectable	Intranasal / Spray
End User	Poultry Farms, Veterinary Clinics & Hospitals, Government & Research Institutes	Poultry Farms	Veterinary Clinics & Hospitals
Distribution Channel	Hospital / Veterinary Pharmacies, Direct Sales / Manufacturer Channels, Online Platforms	Hospital / Veterinary Pharmacies	Online Platforms

MARKET SEGMENTATION OVERVIEW

By Disease Type

Sub-Segment	Key Trend
Infectious Bronchitis	Persistent variant emergence sustains rolling reformulation demand
Avian Influenza	Government stockpiling and emergency-use authorizations drive volume
Newcastle Disease	Compulsory vaccination mandates in Asia and Africa
Infectious Bursal Disease	Maternal immunity transfer programs in breeder flocks
Marek's Disease	Universal in-ovo hatchery vaccination protocols
Others	Mycoplasma, coccidiosis, and laryngotracheitis niche segments

Infectious bronchitis and avian influenza together account for the largest share of disease-targeted vaccine revenues. Variant evolution in both disease categories ensures continuous demand for updated antigen formulations.

By Technology

Sub-Segment	Key Trend
Live Attenuated Vaccines	Mass-application via drinking water and spray remains cost-effective
Inactivated / Killed Vaccines	Essential for booster protocols in long-lived breeder and layer flocks
Recombinant / Vector Vaccines	Multivalent in-ovo platforms gaining rapid market share
Toxoid and Subunit Vaccines	Niche use in clostridial disease and free-range operations

Recombinant HVT-vector products represent the fastest-growing technology platform, combining multiple antigens into single-dose hatchery injections that reduce handling events and improve immune uniformity.

By Application

Sub-Segment	Key Trend
Breeder Flocks	Most comprehensive vaccination schedules; 15–20 doses per cycle
Layer Flocks	Rapidly expanding as egg production scales in Asia
Broiler Flocks	Volume-driven demand; in-ovo automation increasing penetration

Breeder-flock programs remain the revenue anchor because breeders receive the most intensive vaccination protocols to ensure robust maternal antibody transfer to commercial progeny.

By Dosage Form

Sub-Segment	Key Trend
Liquid Formulations	Compatible with injectable and drinking-water delivery methods
Powder / Lyophilized	Thermostability advantageous for off-grid and tropical markets
Dust and Aerosol	Growing adoption through automated hatchery spray cabinets

Powder and lyophilized formats are the fastest-growing dosage category, driven by demand for cold-chain-independent products in Africa, South Asia, and rural Southeast Asia.

By Route of Administration

Sub-Segment	Key Trend
Injectable	Standard for inactivated booster doses in breeders and layers
Drinking Water	Low-cost mass application for live attenuated products
Intranasal / Spray	Mucosal immunity advantage; hatchery automation compatible
In-Ovo	Single-dose efficiency; rapid adoption in automated hatcheries

Intranasal and spray delivery routes are gaining traction as hatchery spray-cabinet technology improves dose uniformity across large-volume operations.

By End User

Sub-Segment	Key Trend
Poultry Farms	Direct procurement dominates in vertically integrated operations
Veterinary Clinics & Hospitals	Advisory-service bundling growing among smallholder segments
Government & Research Institutes	Stockpiling, field surveillance, and clinical trial programs

Poultry farms remain the dominant end-user channel, but veterinary clinics are growing fastest as advisory services and bundled health programs gain traction among smaller-scale producers.

By Distribution Channel

Sub-Segment	Key Trend
Hospital / Veterinary Pharmacies	Established cold-chain infrastructure and prescription compliance
Direct Sales / Manufacturer Channels	Integrated producer procurement contracts
Online Platforms	E-ordering with cold-chain tracking expanding rural access

Online and direct sales platforms represent the fastest-growing distribution channel, driven by digitized ordering systems that shorten lead times and document cold-chain integrity from manufacturer to farm gate.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”